ADC	Antibody–drug conjugate
ASCO	American Society of Clinical Oncology
AR	Androgen receptor
CAP	American Society of Clinical Oncology
CK 5/6	Cytokeratin 5/6
CI	Confidence intervals
DCC	Dextran-coated charcoal
EGFR	Epidermal growth factor receptor
ER	Estrogen receptor
FISH	Fluorescence in situ hybridization
FOXA1	Forkhead box protein A1
HER2	Human epidermal growth factor receptor 2
HR	Hazard ratio
IHC	Immunohistochemistry
ISH	in situ hybridization
OS	Overall survival
PD-L1	Programmed death-ligand 1
PR	Progesterone receptor
RFS	Relapse-free survival
TILs	Tumor-infiltrating lymphocytes
TNBC	Triple-negative breast cancer